Loading
Latest filing published 28 Jan 2019 for Abattis Bioceuticals Corp..
No signal scores available.
One trade, one date: on 28 January 2019, Cedric Paul Wilson disclosed an open-market sale in Abattis Bioceuticals Corp. No broader history exists yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration